Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03992352 · ClinicalTrials.gov registry record
Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704)
A clinical trial, sponsored by Center for International Blood and Marrow Transplant Research.
- Completed
- Registry status
- 1,229
- Enrollment target
NCT03992352 is a clinical trial that has completed, run by Center for International Blood and Marrow Transplant Research. The registered enrollment target is 1,229 participants.
The verdict
NCT03992352 has completed, sponsored by Center for International Blood and Marrow Transplant Research.
- COMPLETED
- Registry status
- 1,229 participants
- Enrollment target
Study Summary
Prospective observational multicenter study of allogeneic Hematopoietic Stem Cell Transplantation (HCT) in recipients 60 years and older to assess important determinants of health status to be combined into a composite health risk model to improve risk assessment of non-relapse mortality (NRM).
Interventions
- DIAGNOSTIC_TEST Age 60+ with planned HCT for Hematologic Malignancy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,229 participants |
| Start Date | 2019-07-19 |
| Est. Completion | 2023-05-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03992352
The ClinicalTrials.gov registry entry for NCT03992352 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,229 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Center for International Blood and Marrow Transplant Research, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Age 60+ with planned HCT for Hematologic Malignancy is the first listed.
NCT03992352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03992352 about?
NCT03992352 is a clinical study titled "Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704)". Prospective observational multicenter study of allogeneic Hematopoietic Stem Cell Transplantation (HCT) in recipients 60 years and older to assess important determinants of health status to be combined into a composite health risk model to improve risk assessment of non-relapse mortality (NRM).
What is the current status of trial NCT03992352?
This trial is currently completed. The enrollment target is 1,229 participants. The study started on 2019-07-19. Estimated completion is 2023-05-30.
What interventions are being tested in trial NCT03992352?
The interventions under investigation include: Age 60+ with planned HCT for Hematologic Malignancy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03992352?
This trial is sponsored by Center for International Blood and Marrow Transplant Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.